'Unmovable monster': The drug trial that changed how biotechs approach rare disease treatments
December 23, 2021 at 11:57 AM EST
The effects of the trial that began 10 years ago this past summer can still be seen today in the approach biotech companies take to developing drugs for rare diseases.
